Leo Luznik

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide”.

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020001729

N/A

5.5DataRank · unranked

149 citations

Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone +12 more

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Advances(2020)10.1182/bloodadvances.2020001648

N/A

3.1DataRank · unranked

74 citations

Marianna Zahurak, Yilin Cao, Allen Chen, Kenneth R. Cooke, Christopher Gamper +16 more

Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

Journal of Clinical Investigation(2022)10.1172/jci159579

N/A

2.3DataRank · unranked

94 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +16 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

Treatment of AML Relapse After Allo-HCT

Frontiers in Oncology(2021)10.3389/fonc.2021.812207

N/A

0DataRank · unranked

36 citations

Leo Luznik, Ivana Gojo, Jonathan Webster

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022

N/A

0DataRank · unranked

6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

UNC Libraries(2021)10.17615/vfd1-7m89

N/A

0DataRank · unranked

3 citations

Geoffrey R. Hill, Steven M. Devine, Jason A. Dubovsky, Samantha Jaglowski, Bruce R. Blazar +25 more

How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond

Blood(2022)10.1182/blood.2021015129

N/A

0DataRank · unranked

60 citations

Shannon R. McCurdy, Leo Luznik, Joseph Rimando

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Blood Advances(2022)10.1182/bloodadvances.2022007611

N/A

0DataRank · unranked

33 citations

Gèrard Socié, Geoffrey R. Hill, Kelli P. A. MacDonald, Victor Tkachev, Takanori Teshima +11 more

Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel

British Journal of Haematology(2022)10.1111/bjh.18454

N/A

0DataRank · unranked

25 citations

Ana Lazarevic, Jamie E. Ziggas, Ephraim J. Fuchs, Kiryoung Kim, Helen Byrnes +7 more

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.009

N/A

0DataRank · unranked

11 citations

Michael Sang Hughes, Hua‐Ling Tsai, Kathryn Yarkony, Ephraim J. Fuchs, Lode J. Swinnen +15 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

medRxiv(2022)10.1101/2022.02.08.22270578

N/A

0DataRank · unranked

3 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +14 more

Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight

Blood Reviews(2023)10.1016/j.blre.2023.101093

N/A

0DataRank · unranked

20 citations

Leo Luznik, Shannon R. McCurdy

Chronic graft-versus-host disease: unresolved complication or ancient history?

Blood(2024)10.1182/blood.2023022735

N/A

0DataRank · unranked

35 citations

Ted Gooley, Leo Luznik, Bruce R. Blazar, Joseph A. Pidala

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity

Nature Cancer(2024)10.1038/s43018-024-00736-x

N/A

0DataRank · unranked

30 citations

Xin He, Lei Zhang, Wei Chen, Yi‐Chun Lin, Songbai Liu +27 more

Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.09.018

N/A

0DataRank · unranked

11 citations

Hua-Ling Tsai, Amy E. DeZern, Kevin Jerde, Lode J. Swinnen, Javier Bolaños‐Meade +13 more

Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.012

N/A

0DataRank · unranked

35 citations

Marianna Zahurak, Leo Luznik, Richard F. Ambinder, Ephraim J. Fuchs, Javier Bolaños‐Meade +7 more